Pfizer unveils $600m investment in venture capital arm
Pfizer is planning to invest $600 million in biotechnology and other emerging growth companies through its venture investment group.
Read More
Tag: Pfizer Ventures
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
